Policy Watch: 20 Regulatory Updates — April 25, 2026
This Policy Watch covers schedules of controlled substances placement April 2026 updates relevant to cannabis clinicians. The DEA's recent scheduling actions affect synthetic cannabinoids and other substances. These regulatory changes inform clinical and…
LIVE: News Patrol (10AM) | ANC (6 April 2026) – YouTube
This live cannabis news April 2026 update highlights emerging clinical developments and policy insights. It emphasizes evidence-based medicine and clinical standards. Stay current with relevant cannabis clinical updates and news.
Policy Watch: 10 Regulatory Updates — March 18, 2026
This Policy Watch covers the DEA marijuana rescheduling 2026 proposal and other key regulatory updates affecting cannabis clinicians. The rescheduling could facilitate research and patient access by acknowledging medical utility. These regulatory changes…
AM Policy Update: DEA Scheduling and Cannabis Rescheduling March 16, 2026
The DEA scheduling cannabis rescheduling update on March 16, 2026, highlights key regulatory changes affecting cannabis medicine. This includes the temporary placement of several substances in Schedule I and the proposed rescheduling of marijuana. These…
Policy Watch: 16 Regulatory Updates — March 13, 2026
This update covers cannabis medicine regulations 2026, highlighting key controlled substances scheduling and Medicare policy changes. These regulatory updates impact clinical research and patient access. Cannabis clinicians should stay informed on…
Policy Watch: 16 Regulatory Updates — March 11, 2026
This update covers DEA scheduling synthetic cannabinoids and other controlled substances relevant to cannabis clinicians. Medicare and Medicaid policy changes also affect cannabis treatment reimbursement. These regulatory updates shape the clinical…